Rallybio (RLYB) Earnings Analysis
Rallybio (RLYB) next reports earnings on 2026-08-06, consensus EPS -1.28 USD. Last quarter (2026-03-12) it beat with EPS -1.11 USD vs -1.24 USD est (+10.5%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -11.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RLYB next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.28 USD |
| Revenue estimate | 0.00B |
RLYB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -1.11 USD | -1.24 USD | +10.5% | Beat |
| 2025-11-06 | -0.14 USD | -0.25 USD | +44% | Beat |
| 2025-08-07 | -0.22 USD | -0.195 USD | -12.8% | Miss |
| 2025-03-13 | -0.25 USD | -0.27 USD | +7.4% | Beat |
| 2024-11-07 | -0.26 USD | -0.36 USD | +27.8% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
RLYB valuation and analyst view
| Trailing P/E | -11.15 |
|---|---|
| Trailing EPS | -1.37416 USD |
| Price / book | 1.88 |
| Dividend yield | 0.00% |
| Market cap | 0.09B |
| Analyst consensus | Hold (4 buy / 5 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Rallybio (RLYB)'s next earnings date?
Rallybio is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.28 USD and revenue estimate of 0.00B.
Did RLYB beat earnings last quarter?
In its 2026-03-12 report, RLYB posted EPS of -1.11 USD versus a -1.24 USD estimate — a beat of 10.5%.
What is RLYB's earnings track record?
Over the last 5 reported quarters with consensus data, RLYB beat estimates 4 times (80%).
What is RLYB's current P/E ratio and EPS?
RLYB trades at a trailing P/E of -11.15 on trailing EPS of -1.3741556774058359 USD.
What do analysts rate RLYB?
Analyst consensus is "Hold" across 9 ratings (0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell).